Literature DB >> 19010343

Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance-associated protein 2 (abcc2).

Ishtiaq Qadri1, Ling-Jia Hu, Mieko Iwahashi, Subhi Al-Zuabi, Linda C Quattrochi, Francis R Simon.   

Abstract

Multidrug resistance-associated protein 2 (MRP2) (ABCC2) is an ATP-binding cassette membrane protein located primarily on apical surface of hepatocytes that mediates transport of conjugated xenobiotics and endogenous compounds into bile. MRP2 is highly expressed in hepatocytes, and at lower levels in small intestines, stomach and kidney. Previous reports have characterized mammalian MRP2 promoters, but none have established the molecular mechanism(s) involved in liver enriched expression. This study aims to investigate the mechanism of hepatic MRP2 regulation. A 2130 bp of MRP2 promoter was cloned from PAC-1 clone P108G1-7, to identify putative liver specific/hormone responsive functional DNA binding sites. Using deletion analysis, site specific mutagenesis and co-transfection studies, liver specific expression was determined. MRP2 promoter-LUC constructs were highly expressed in liver cell lines compared to non-liver cells. The region extending from -3 to+458 bp of MRP2 promoter starting from AUG contained the potential binding sites for CAATT box enhancer binding protein (C/EBP), hepatocytes nuclear factor 1, 3 and 4 (HNF1, HNF3, and HNF4. Only HNF1 and HNF4 co-transfection with MRP2 luciferase increased expression. Site specific mutational analysis of HNF1 binding site indicated an important role for HNF1alpha. HNF4alpha induction of MRP2 was independent of HNF1 binding site. C/EBP, HNF3, and HNF6 inhibited HNF1alpha while HNF4alpha induced MRP2 luciferase expression and glucocorticoids stimulated MRP2 expression. This study emphasizes the complex regulation of MRP2 with HNF1alpha and HNF4alpha playing a central role. The coordinated regulation of xenobiotic transporters and oxidative conjugation may determine the adaptive responses to cellular detoxification processes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19010343     DOI: 10.1016/j.taap.2008.10.005

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  15 in total

1.  Modification in oxidative stress, inflammation, and lipoprotein assembly in response to hepatocyte nuclear factor 4alpha knockdown in intestinal epithelial cells.

Authors:  Valérie Marcil; Ernest Seidman; Daniel Sinnett; François Boudreau; Fernand-Pierre Gendron; Jean-François Beaulieu; Daniel Ménard; Louis-Philippe Precourt; Devendra Amre; Emile Levy
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

2.  Differential transcriptional characteristics of small and large biliary epithelial cells derived from small and large bile ducts.

Authors:  S Glaser; M Wang; Y Ueno; J Venter; K Wang; H Chen; G Alpini; A Holterman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-24       Impact factor: 4.052

Review 3.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

4.  The ERK1/2-hepatocyte nuclear factor 4alpha axis regulates human ABCC6 gene expression in hepatocytes.

Authors:  Hugues de Boussac; Marcin Ratajewski; Iwona Sachrajda; Gabriella Köblös; Attila Tordai; Lukasz Pulaski; László Buday; András Váradi; Tamás Arányi
Journal:  J Biol Chem       Date:  2010-05-12       Impact factor: 5.157

5.  C/EBPβ is AMP kinase sensitive and up-regulates PEPCK in response to ER stress in hepatoma cells.

Authors:  Mahua Choudhury; Ishtiaq Qadri; Shaikh Mizanoor Rahman; Jill Schroeder-Gloeckler; Rachel C Janssen; Jacob E Friedman
Journal:  Mol Cell Endocrinol       Date:  2010-08-24       Impact factor: 4.102

6.  Population Pharmacokinetics of Mycophenolic Acid Co-Administered with Tacrolimus in Corticosteroid-Free Adult Kidney Transplant Patients.

Authors:  Yan Rong; Patrick Mayo; Mary H H Ensom; Tony K L Kiang
Journal:  Clin Pharmacokinet       Date:  2019-11       Impact factor: 6.447

7.  Optimization of Canalicular ABC Transporter Function in HuH-7 Cells by Modification of Culture Conditions.

Authors:  Hee Eun Kang; Melina M Malinen; Chitra Saran; Paavo Honkakoski; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2019-08-01       Impact factor: 3.922

8.  Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression.

Authors:  T D Nguyen; S Markova; W Liu; J M Gow; R M Baldwin; M Habashian; M V Relling; M J Ratain; D L Kroetz
Journal:  Pharmacogenomics J       Date:  2012-06-05       Impact factor: 3.550

9.  Hepatocyte nuclear factor 1alpha plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine.

Authors:  Hai Li; Bin Dong; Sahng Wook Park; Hyun-Sook Lee; Wei Chen; Jingwen Liu
Journal:  J Biol Chem       Date:  2009-08-17       Impact factor: 5.157

10.  Expression of HNF4alpha in the human and rat choroid plexus: implications for drug transport across the blood-cerebrospinal-fluid (CSF) barrier.

Authors:  Monika Niehof; Jürgen Borlak
Journal:  BMC Mol Biol       Date:  2009-07-03       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.